MAZZEO, ROBERTA
MAZZEO, ROBERTA
DMED - DIPARTIMENTO DI MEDICINA
Chemotherapy in patients with early breast cancer: clinical overview and management of long-term side effects
2022-01-01 Di Nardo, P.; Lisanti, C.; Garutti, M.; Buriolla, S.; Alberti, M.; Mazzeo, R.; Puglisi, F.
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy
2023-01-01 Garufi, Giovanna; Carbognin, Luisa; Sperduti, Isabella; Miglietta, Federica; Dieci, Maria Vittoria; Mazzeo, Roberta; Orlandi, Armando; Gerratana, Lorenzo; Palazzo, Antonella; Fabi, Alessandra; Paris, Ida; Franco, Antonio; Franceschini, Gianluca; Fiorio, Elena; Pilotto, Sara; Guarneri, Valentina; Puglisi, Fabio; Conte, Pierfranco; Milella, Michele; Scambia, Giovanni; Tortora, Giampaolo; Bria, Emilio
Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva
2020-01-01 Bartoletti, M.; Mazzeo, R.; De Scordilli, M.; Del Fabro, A.; Vitale, M. G.; Bortot, L.; Nicoloso, M. S.; Corsetti, S.; Bonotto, M.; Scalone, S.; Giorda, G.; Sorio, R.; Andreetta, C.; Meacci, M. L.; De Vivo, R.; Fasola, G.; Sopracordevole, F.; Puglisi, F.
Immunotherapy in the Treatment of Advanced or Recurrent Endometrial Cancer
2024-01-01 Grau-Bejar, J. F.; Farinas-Madrid, L.; Garcia-Duran, C.; Garcia-Illescas, D.; Mazzeo, R.; Oaknin, A.
Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis
2024-01-01 Bartoletti, M.; Montico, M.; Lorusso, D.; Mazzeo, R.; Oaknin, A.; Musacchio, L.; Scambia, G.; Puglisi, F.; Pignata, S.
Liquid biopsy in triple-negative breast cancer: unlocking the potential of precision oncology
2024-01-01 Mazzeo, R; Sears, J; Palmero, L; Bolzonello, S; Davis, A A; Gerratana, L; Puglisi, F
The evolving landscape of antibody-drug conjugates in ovarian cancer: new drugs for a new era
2024-01-01 Garcia-Illescas, D.; Mazzeo, R.; Garcia-Duran, C.; Oaknin, A.
The Impact of Cereal Grain Composition on the Health and Disease Outcomes
2022-01-01 Garutti, Mattia; Nevola, Gerardo; Mazzeo, Roberta; Cucciniello, Linda; Totaro, Fabiana; Alejandro Bertuzzi, Carlos; Caccialanza, Riccardo; Pedrazzoli, Paolo; Puglisi, Fabio
“Intestinal-Type” Vulvar Adenocarcinoma: A Review of the MITO Rare Tumors Group
2022-01-01 Dellino, M.; Cicogna, S.; Falcone, F.; Mitidieri, M.; Mazzeo, R.; Pignata, S.; Mangili, G.; Cormio, G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Chemotherapy in patients with early breast cancer: clinical overview and management of long-term side effects | 1-gen-2022 | Di Nardo, P.; Lisanti, C.; Garutti, M.; Buriolla, S.; Alberti, M.; Mazzeo, R.; Puglisi, F. | |
| Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy | 1-gen-2023 | Garufi, Giovanna; Carbognin, Luisa; Sperduti, Isabella; Miglietta, Federica; Dieci, Maria Vittoria; Mazzeo, Roberta; Orlandi, Armando; Gerratana, Lorenzo; Palazzo, Antonella; Fabi, Alessandra; Paris, Ida; Franco, Antonio; Franceschini, Gianluca; Fiorio, Elena; Pilotto, Sara; Guarneri, Valentina; Puglisi, Fabio; Conte, Pierfranco; Milella, Michele; Scambia, Giovanni; Tortora, Giampaolo; Bria, Emilio | |
| Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva | 1-gen-2020 | Bartoletti, M.; Mazzeo, R.; De Scordilli, M.; Del Fabro, A.; Vitale, M. G.; Bortot, L.; Nicoloso, M. S.; Corsetti, S.; Bonotto, M.; Scalone, S.; Giorda, G.; Sorio, R.; Andreetta, C.; Meacci, M. L.; De Vivo, R.; Fasola, G.; Sopracordevole, F.; Puglisi, F. | |
| Immunotherapy in the Treatment of Advanced or Recurrent Endometrial Cancer | 1-gen-2024 | Grau-Bejar, J. F.; Farinas-Madrid, L.; Garcia-Duran, C.; Garcia-Illescas, D.; Mazzeo, R.; Oaknin, A. | |
| Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis | 1-gen-2024 | Bartoletti, M.; Montico, M.; Lorusso, D.; Mazzeo, R.; Oaknin, A.; Musacchio, L.; Scambia, G.; Puglisi, F.; Pignata, S. | |
| Liquid biopsy in triple-negative breast cancer: unlocking the potential of precision oncology | 1-gen-2024 | Mazzeo, R; Sears, J; Palmero, L; Bolzonello, S; Davis, A A; Gerratana, L; Puglisi, F | |
| The evolving landscape of antibody-drug conjugates in ovarian cancer: new drugs for a new era | 1-gen-2024 | Garcia-Illescas, D.; Mazzeo, R.; Garcia-Duran, C.; Oaknin, A. | |
| The Impact of Cereal Grain Composition on the Health and Disease Outcomes | 1-gen-2022 | Garutti, Mattia; Nevola, Gerardo; Mazzeo, Roberta; Cucciniello, Linda; Totaro, Fabiana; Alejandro Bertuzzi, Carlos; Caccialanza, Riccardo; Pedrazzoli, Paolo; Puglisi, Fabio | |
| “Intestinal-Type” Vulvar Adenocarcinoma: A Review of the MITO Rare Tumors Group | 1-gen-2022 | Dellino, M.; Cicogna, S.; Falcone, F.; Mitidieri, M.; Mazzeo, R.; Pignata, S.; Mangili, G.; Cormio, G. |